布拉迪酵母菌
益生菌
抗生素相关性腹泻
腹泻
医学
抗生素
不利影响
重症监护医学
生物
微生物学
内科学
细菌
遗传学
艰难梭菌
作者
Zorica Tomičić,Radmilo Čolović,Ivana Čabarkapa,Djuro Vukmirovic,Olivera Djuragic,Ružica Tomičić
出处
期刊:Food & Feed Research
[Institute for Food Technology, Novi Sad]
日期:2016-01-01
卷期号:43 (2): 103-110
被引量:28
摘要
Saccharomyces boulardii is unique probiotic and biotherapeutic yeast, known to survive in gastric acidity and it is not adversely affected or inhibited by antibiotics or does not alter or adversely affect the normal microbiota. S. boulardii has been utilized worldwide as a probiotic supplement to support gastrointestinal health. The multiple mechanisms of action of S. boulardii and its properties may explain its efficacy and beneficial effects in acute and chronic gastrointestinal diseases that have been confirmed by clinical trials. Caution should be taken in patients with risk factors for adverse events. Its potential application in various dairy foods could offer an alternative probiotic product to people suffering from antibiotic-associated diarrhea. This review discusses the evidence for efficacy and safety of S. boulardii as a probiotic for the prevention and therapy of gastrointestinal disorders in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI